Pathstone Family Office’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$1.43M Buy
5,576
+4,055
+267% +$1.04M 0.01% 568
2023
Q2
$455K Buy
1,521
+203
+15% +$60.7K 0.01% 792
2023
Q1
$366K Sell
1,318
-4,526
-77% -$1.26M 0.01% 824
2022
Q4
$1.37M Buy
5,844
+983
+20% +$230K 0.01% 643
2022
Q3
$1.3M Buy
4,861
+3,149
+184% +$840K 0.01% 619
2022
Q2
$349K Buy
1,712
+173
+11% +$35.2K 0.01% 723
2022
Q1
$325K Buy
1,539
+21
+1% +$4.44K 0.01% 717
2021
Q4
$365K Buy
1,518
+629
+71% +$151K 0.01% 651
2021
Q3
$251K Sell
889
-10
-1% -$2.82K 0.01% 730
2021
Q2
$311K Buy
899
+91
+11% +$31.5K 0.01% 632
2021
Q1
$226K Buy
808
+248
+44% +$69.4K 0.01% 570
2020
Q4
$137K Buy
560
+107
+24% +$26.2K 0.01% 329
2020
Q3
$128K Hold
453
0.01% 243
2020
Q2
$122K Sell
453
-321
-41% -$86.5K 0.01% 200
2020
Q1
$244K Buy
774
+607
+363% +$191K 0.03% 150
2019
Q4
$496K Hold
167
0.01% 299
2019
Q3
$39K Hold
167
0.01% 302
2019
Q2
$39K Sell
167
-360
-68% -$84.1K ﹤0.01% 359
2019
Q1
$124K Buy
527
+10
+2% +$2.35K 0.02% 213
2018
Q4
$155K Hold
517
0.04% 97
2018
Q3
$182K Buy
517
+50
+11% +$17.6K 0.06% 55
2018
Q2
$136K Sell
467
-50
-10% -$14.6K 0.1% 54
2018
Q1
$142K Buy
517
+150
+41% +$41.2K 0.08% 56
2017
Q4
$117K Sell
367
-83
-18% -$26.5K 0.06% 44
2017
Q3
$120K Sell
450
-117
-21% -$31.2K 0.11% 51
2017
Q2
$153K Buy
567
+195
+52% +$52.6K 0.06% 121
2017
Q1
$102K Buy
+372
New +$102K 0.06% 129
2016
Q4
Sell
-367
Closed -$115K 109
2016
Q3
$115K Hold
367
0.12% 39
2016
Q2
$88K Hold
367
0.08% 40
2016
Q1
$95K Buy
367
+312
+567% +$80.8K 0.19% 33
2015
Q4
$17K Buy
+55
New +$17K 0.08% 34
2014
Q4
Sell
-113
Closed -$37K 123
2014
Q3
$37K Buy
+113
New +$37K 0.11% 67